4.7 Article

Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients

Simone de Vries et al.

Summary: Compared with the general population, Hodgkin lymphoma survivors have a substantially reduced life expectancy. Therefore, optimal selection of patients for primary CT is crucial, weighing risks of HL relapse and long-term toxicity.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Review Medicine, General & Internal

Classical Hodgkin lymphoma

Pauline Brice et al.

Summary: Classical Hodgkin lymphoma is a relatively common lymphoma that is generally considered highly curable with standard first-line chemotherapy and radiotherapy, although some patients may not be cured or may experience late toxic effects leading to premature death. Recent changes in the gold standard of chemotherapy, now often including immunotherapy in relapse settings, have further impacted treatment outcomes.

LANCET (2021)

Review Oncology

Molecular biology of Hodgkin lymphoma

Marc A. Weniger et al.

Summary: Classical Hodgkin lymphoma (cHL) has unique biological features such as the orchestration of a complex microenvironment by HRS cells, the major role of Epstein-Barr virus in lymphomagenesis, and the defining interplay of genetic lesions and cellular origin. These factors contribute to the constitutive activation of multiple signaling pathways in cHL.

LEUKEMIA (2021)

Article Oncology

Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis

Jie Gao et al.

Summary: The study confirmed an increasing risk of non-cancer-specific death in adult patients with cHL, primarily due to cardiovascular disease and malignant tumors. Non-CSD had a negative impact on overall survival rates, emphasizing the need for close monitoring. A competing risk model was deemed more suitable for predicting the prognosis of patients with cHL compared to the Cox proportional hazards model.

BMC CANCER (2021)

Article Oncology

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma

David J. Cutter et al.

Summary: This study aims to provide information on the risk of radiation-related cardiovascular disease in early-stage Hodgkin lymphoma patients to help personalize radiotherapy delivery. The predicted excess cardiovascular risk is small for most patients, suggesting that radiotherapy may provide a net benefit.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Review Oncology

Cardiovascular effects of Hodgkin's lymphoma: a review of literature

Aasems Jacob et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)

Article Hematology

Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management

Stephen M. Ansell

AMERICAN JOURNAL OF HEMATOLOGY (2018)

Letter Cardiac & Cardiovascular Systems

Cardiovascular Disease Risk After Treatment-Induced Premature Ovarian Insufficiency in Female Survivors of Hodgkin Lymphoma

Inge M. Krul et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Oncology

Cancer Statistics, 2016

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Oncology

Trends and Disparities in Cardiovascular Mortality Among Survivors of Hodgkin Lymphoma

Sadeer G. Al-Kindi et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)

Article Oncology

Impact of Cardiovascular Counseling and Screening in Hodgkin Lymphoma Survivors

Laurien A. Daniels et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)

Article Oncology

Mortality is persistently increased in Hodgkin's lymphoma survivors

Cecilie E. Kiserud et al.

EUROPEAN JOURNAL OF CANCER (2010)

Article Medicine, General & Internal

Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy

MC Hull et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)

Article Oncology

Long-term cause-specific mortality of patients treated for Hodgkin's disease

BMP Aleman et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)